MA (EU) 
number 
(Invented
) name 
Strength 
Pharmaceutica
l Form 
Route of 
Administratio
n 
Immediat
e 
Packaging 
Content 
(concentration) 
Pack size 
EU/1/08/492/001 
RoActemra 
20 mg/ml 
EU/1/08/492/002 
RoActemra 
20 mg/ml 
EU/1/08/492/003 
RoActemra 
20 mg/ml 
EU/1/08/492/004 
RoActemra 
20 mg/ml 
EU/1/08/492/005 
RoActemra 
20 mg/ml 
EU/1/08/492/006 
RoActemra 
20 mg/ml 
EU/1/08/492/007 
RoActemra 
162 mg 
vial (glass) 
vial (glass) 
Intravenous use 
Intravenous use 
Intravenous use 
Concentrate for 
solution for 
infusion 
Concentrate for 
solution for 
infusion 
Concentrate for 
solution for 
infusion 
Concentrate for 
solution for 
infusion 
Concentrate for 
solution for 
infusion 
Concentrate for 
solution for 
infusion 
Solution for injection  Subcutaneous use  pre-filled 
Intravenous use 
Intravenous use 
Intravenous use 
vial (glass) 
vial (glass) 
vial (glass) 
vial (glass) 
EU/1/08/492/008 
RoActemra 
162 mg 
Solution for injection  Subcutaneous use  pre-filled 
syringe (glass) 
syringe (glass) 
4 ml 
4 ml 
1 vial 
4 vials 
10 ml 
1 vial 
10 ml 
4 vials 
20 ml 
1 vial 
20 ml 
4 vials 
0.9 ml (180 mg/ml)  4 pre-filled syringes 
0.9 ml (180 mg/ml)  12 (3 x 4) pre-
filled syringes 
(multipack) 
EU/1/08/492/009 
RoActemra 
162 mg 
Solution for injection  Subcutaneous use  pre-filled 
0.9 ml (180 mg/ml)  4 pre-filled pens 
EU/1/08/492/010 
RoActemra 
162 mg 
Solution for injection  Subcutaneous use  pre-filled 
0.9 ml (180 mg/ml)  12 (3 x 4) pre-
syringe (glass) in 
a pen 
filled pens 
(multipack) 
syringe (glass) in 
a pen 
1/1 
 
 
 
 
 
 
 
 
  
